Effect of garlic on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled clinical trials

Nutrition

Volumn 32, Issue 1, 2016, Pages 33-40

  Sahebkar, Amirhossein ^a,b   Serban, Corina ^c   Ursoniu, Sorin ^c   Banach, Maciej ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Allium sativum; Garlic; Lipids; Lipoprotein(a)

Indexed keywords

CHOLESTEROL; GARLIC EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; LIPOPROTEIN A; PLANT MEDICINAL PRODUCT;

ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRUG EFFECT; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROTEIN ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; BLOOD; DIETARY SUPPLEMENT; GARLIC;

DIETARY SUPPLEMENTS; GARLIC; HUMANS; LIPOPROTEIN(A); PLANT PREPARATIONS;

EID: 84954438771     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.06.009     Document Type: Article

References (51)

1. Ramasamy I. Recent advances in physiological lipoprotein metabolism. Clin Chem Lab Med 2014, 52:1695-1727.
2. Kotani K., Sahebkar A., Serban C., Andrica F., Toth P.P., Jones S.R., et al. Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients. Atherosclerosis 2015, 242:87-96.
3. Clarke R., Peden J.F., Hopewell J.C., Kyriakou T., Goel A., Heath S.C., et al. Genetic variants associated with Lp (a) lipoprotein level and coronary disease. N Engl J Med 2009, 361:2518-2528.
4. Tada H., Kawashiri M.A., Nohara A., Inazu A., Mabuchi H., Yamagishi M. Lipoprotein(a) in familial hypercholesterolemia with proprotein convertase subtilisin kexin type 9 gain-of-function mutations: implication of residual risk in statin-era. J Am Coll Cardiol 2015, 65:61371-61375.
5. Banach M., Aronow W.S., Serban C., Sahabkar A., Rysz J., Voroneanu L., et al. Lipids, blood pressure and kidney update 2014. Pharmacol Res 2015, 95-96:111-125.
6. Dragan S., Serban M.C., Banach M. Proprotein convertase subtilisin/kexin 9 inhibitors: an emerging lipid-lowering therapy?. J Cardiovasc Pharmacol Ther 2015, 20:157-168.
7. Sobenin I.A., Korneev N.V., Romanov I.V., Shutikhina I.V., Kuntsevich G.I., Romanenko E.B., et al. The effects of garlic powder tablets in subclinical carotid atherosclerosis. Exp Clin Cardiol 2014, 20:629-638.
8. Lawson L. The composition and chemistry of garlic cloves and processed garlic. Garlic: the science and therapeutic application of Allium sativum L 1996, 37-108. Williams and Wilkins, Baltimore, MD.
9. Zhou H., Li W., Zhou M., Hu X., Ou S., Yan R., et al. Characterization of phenolic constituents inhibiting the formation of sulfur-containing volatiles produced during garlic processing. J Agric Food Chem 2015, 63:787-794.
10. Suleria H.A., Butt M.S., Khalid N., Sultan S., Raza A., Aleem M., et al. Garlic (Allium sativum): diet based therapy of 21st century-a review. Asian Pac J Trop Dis 2015, 5:271-278.
11. Vinson J.A., Su X., Zubik L., Bose P. Phenol antioxidant quantity and quality in foods: fruits. J Agric Food Chem 2001, 49:5315-5321.
12. Macpherson L.J., Geierstanger B.H., Viswanath V., Bandell M., Eid S.R., Hwang S., et al. The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin. Curr Biol 2005, 15:929-934.
13. Wei X., Pang J., Zhang C., Yu C., Chen H., Xie B. Structure and properties of moisture-resistant konjac glucomannan films coated with shellac/stearic acid coating. Carbohydr Polym 2015, 118:119-125.
14. Edwards S.E., da Costa Rocha I., Williamson E.M., Heinrich M. Garlic Allium sativum L. Phytopharm 2015, 158.
15. Arreola R., Quintero-Fabián S., López-Roa R.I., Flores-Gutiérrez E.O., Reyes-Grajeda J.P., Carrera-Quintanar L., et al. Immunomodulation and anti-inflammatory effects of garlic compounds. J Immunol Res 2015, 2015:401630.
16. Lau B.H. Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit. J Nutr 2006, 136:765S-768S.
17. Bordia A., Verma S., Srivastava K. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1998, 58:257-263.
18. Xiong X., Wang P., Li S., Li X., Zhang Y., Wang J. Garlic for hypertension: a systematic review and meta-analysis of randomized controlled trials. Phytomedicine 2015, 22:352-361.
19. Wang H.P., Yang J., Qin L.Q., Yang X.J. Effect of garlic on blood pressure: a meta-analysis. J Clin Hyperten 2015, 17:223-231.
20. Hom C., Budoff M., Luo Y. The effects of aged garlic extract on coronary artery calcification progression and blood pressure. J Am Coll Cardiol 2015, 65.
21. Bergmark C., Dewan A., Orsoni A., Merki E., Miller E.R., Shin M.J., et al. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res 2008, 49:2230-2239.
22. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
23. Higgins J., Green S. Cochrane Handbook for Systematic Reviews of Interventions 2010, Version 5.0. 2 2009, John Wiley and Sons Ltd, Chichester, UK.
24. Borenstein M., Hedges L., Higgins J., Rothstein H. Comprehensive meta-analysis version 2 2005, 104. Biostat, Englewood, NJ.
25. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13.
26. Sahebkar A. Does PPARγ2 gene Pro12 Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA Cell Biol 2013, 32:188-198.
27. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 2014, 28:633-642.
28. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
29. McCrindle B.W., Helden E., Conner W.T. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1998, 152:1089-1094.
30. Superko H.R., Krauss R.M. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein (a). J Am Coll Cardiol 2000, 35:321-326.
31. Byrne D., Neil H., Vallance D., Winder A. A pilot study of garlic consumption shows no significant effect on markers of oxidation or sub-fraction composition of low-density lipoprotein including lipoprotein (a) after allowance for non-compliance and the placebo effect. Clin Chim Acta 1999, 285:21-33.
32. Simons L.A., Balasubramaniam S., von Konigsmark M., Parfitt A., Simons J., Peters W. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 1995, 113:219-225.
33. Isaacsohn J.L., Moser M., Stein E.A., Dudley K., Davey J.A., Liskov E., et al. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998, 158:1189-1194.
34. Budoff M.J., Ahmadi N., Gul K.M., Liu S.T., Flores F.R., Tiano J., et al. Aged garlic extract supplemented with B vitamins, folic acid and l-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med 2009, 49:101-107.
35. Khoo Y.S., Aziz Z. Garlic supplementation and serum cholesterol: a meta-analysis. J Clin Pharm Ther 2009, 34:133-145.
36. Neil H.A., Silagy C.A., Lancaster T., Hodgeman J., Vos K., Moore J.W., et al. Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Physicians Lond 1996, 30:329-334.
37. Reinhart K.M., Talati R., White C.M., Coleman C.I. The impact of garlic on lipid parameters: a systematic review and meta-analysis. Nutr Res Rev 2009, 22:39-48.
38. Ried K., Toben C., Fakler P. Effect of garlic on serum lipids: an updated meta-analysis. Nutr Rev 2013, 71:282-299.
39. Silagy C., Neil A. Garlic as a lipid lowering agent-a meta-analysis. J R Coll Physicians Lond 1994, 28:39-45.
40. Stevinson C., Pittler M.H., Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 2000, 133:420-429.
41. Warshafsky S., Kamer R.S., Sivak S.L. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 1993, 119:599-605.
42. Bloem E., Haneklaus S., Schnug E. Storage life of field-grown garlic bulbs (Allium sativum L.) as influenced by nitrogen and sulfur fertilization. J Agric Food Chem 2011, 59:4442-4447.
43. Fei M.L., Tong L., Wei L., De Yang L. Changes in antioxidant capacity, levels of soluble sugar, total polyphenol, organosulfur compound and constituents in garlic clove during storage. Ind Crops Prod 2015, 69:137-142.
44. Staba E.J., Lash L., Staba J.E. A commentary on the effects of garlic extraction and formulation on product composition. J Nutr 2001, 131:1118S-1119S.
45. Lawson L.D. Garlic: a review of its medicinal effects and indicated active compounds. Blood 1998, 179:62.
46. Reuter H.D., Koch H., Lawson L. Therapeutic effects and applications of garlic and its preparations. Garlic: the science and therapeutic application of Allium sativum L and related species 1996, 135-213. Williams and Wilkins, Baltimore, MD. H.P. Koch, L.D. Lawson (Eds.).
47. Lawson L.D., Wang Z.J., Papadimitriou D. Allicin release under simulated gastrointestinal conditions from garlic powder tablets employed in clinical trials on serum cholesterol. Planta Med 2001, 67:13-18.
48. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
49. Zhang X.H., Lowe D., Giles P., Fell S., Connock M.J., Maslin D.J. Gender may affect the action of garlic oil on plasma cholesterol and glucose levels of normal subjects. J Nutr 2001, 131:1471-1478.
50. Borrelli F., Capasso R., Izzo A.A. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Ml Nutr Food Res 2007, 51:1386-1397.
51. Tsai C.W., Chen H.W., Sheen L.Y., Lii C.K. Garlic: Health benefits and actions. Biomedicine 2012, 2:17-29.